ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
ECTE was delisted on the 11th of July, 2016.
25 hedge funds and large institutions have $6.97M invested in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in 2014 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 5 closing their positions.
199% more capital invested
Capital invested by funds: $2.33M → $6.97M (+$4.64M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less funds holding
Funds holding: 28 → 25 (-3)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PM
Platinum Management
New York
|
+$5.29M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$241K |
| 3 |
Nomura Holdings
Tokyo,
Japan
|
+$52.1K |
| 4 |
Morgan Stanley
New York
|
+$12.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.83K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$245K |
| 2 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$52.1K |
| 3 |
Jane Street
New York
|
-$46K |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
-$29K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$19.8K |
ECTE Hedge Fund Activity: Q1 2014 in Review
25 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) for Q1 2014, worth a combined $6.97M — up 199% from $2.33M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ECTE and 2 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 5 added.
The largest buyer was Platinum Management, opening a new position worth an estimated $5.29M. The largest seller was Renaissance Technologies, cutting an estimated $245K.
- 25 institutional investors held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) as of Q1 2014, down from 28 in Q4 2013.
- Funds reported $6.97M of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) stock for Q1 2014, up 199% quarter-over-quarter.
- 2 funds opened new ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) positions in Q1 2014 and 5 closed out, a net change of -3 holders.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) buyer in Q1 2014 was Platinum Management, an estimated $5.29M added.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) seller in Q1 2014 was Renaissance Technologies, an estimated $245K sold.
Based on aggregated 13F filings for Q1 2014.